Octagon was founded on scientific insights developed at Harvard. The founding team has a passion for developing new medicines and believes that people living with autoimmunity deserve better treatment options. Octagon is based in downtown Providence, RI and has lab space at The Engine in Cambridge, USA.
Octagon’s team is deeply committed to developing new medicines for diseases with unmet clinical need. The management team includes highly skilled scientists, clinicians, and entrepreneurs with decades of research experience and deep expertise in drug development. The scientific team is growing and continues to add top research talent.
Board of Directors
Isaac Stoner
Director
Co-founder & CEO
Thorne Sparkman
Director
Managing Director, Slater Technology Fund
Peter Kiener
Independent Director
Venture Partner ICG Life Science
Ronald Lennox
Director
Partner, Alia Ventures
Jonathan Thon
Director
Founder, STRM.BIO, Stellular Bio
Scientific Advisors
Michael Elliott, MBBS PhD
Scientific and Clinical Advisor
Fred Ausubel, PhD
Professor of Genetics, Harvard Medical School (Emeritus)
Co-founder
Iain Kilty, PhD
CSO Sitryx
Gregg Silverman, MD
NYU Langone, Professor of Medicine, Professor of Pathology
Shiv Pillai, MD, PhD
Professor of Medicine, Harvard Medical School
